Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 5 43-5, 2001, Pages

  Zimmermann, E M ^a,c   Li, L ^a   Hou, Y T ^a,d   Mohapatra, N K ^b   Pucilowska, J B ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Fibrosis; Inflammation; Inflammatory bowel disease; Smooth muscle cells

Indexed keywords

COLLAGEN TYPE 1; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROHN DISEASE; FIBROBLAST; FIBROSIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATION; INTESTINE RESECTION; LAMINA PROPRIA; MYOFIBROBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

EID: 0035038445     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.5.g1022     Document Type: Article

References (37)

1. Chirgwin J, Przybyla A, Macdonald R, and Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5249-5299, 1979.
2. Chopra R and Anastassiades T. Specificity and synergism of polypeptide growth factors in stimulating the synthesis of proteoglycans and a novel high molecular weight anionic glycoprotein by articular chondrocyte cultures. J Rheumatol 25: 1578-1584, 1998.
3. Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8: 45-62, 1997.
4. Dvorak AM, Osage JE, Monahan RA, and Dickersin DR. Crohn's disease: transmission electron microscopic studies. Hum Pathol 11: 620-634, 1980.
5. Elgin RG, Busby WH Jr, and Clemmons DR. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84: 3254-3258, 1997.
6. Ewton DZ, Coolican SA, Mohan S, Chernausek SD, and Florini JR. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J Cell Physiol 177: 47-57, 1998.
7. Flint DJ, Tonner E, and Allan GJ. Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland. J Mammary Gland Biol Neoplasia 5: 65-73, 2000.
8. Florini JR, Ewton DZ, and McWade FJ. IGFs, muscle growth, and myogenesis. Diabetes Rev 3: 73-92, 1995.
9. Gong Q and Pitas RE. Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J Biol Chem 270: 21672-216788, 1995.
10. Graham MF, Bryson GR, and Diegelmann RF. Transforming growth factor β1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 99: 447-453, 1990.
11. Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, and Gay R. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94: 257-265, 1988.
12. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int 49: S39-S45, 1996.
13. Imai Y, Busby WH Jr, Smith CE, Clarke JB, Garmong AJ, Horwitz GD, Rees C, and Clemmons DR. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. J Clin Invest 100: 2596-2605, 1997.
14. James PL, Stewart CEH, and Rotwein P. Insulin-like growth factor binding protein 5 modulates muscle differentiation through an insulin-like growth factor dependent mechanism. J Cell Biol 133: 683-693, 1996.
15. Jobson TM, Billington CK, and Hall IP. Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation. J Clin Invest 101: 2650-2657, 1998.
16. Jones JI and Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
17. Jones JI, Gockerman A, Busby WH Jr, Camacho-Hubner C, and Clemmons DR. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121: 679-687, 1993.
18. Kuemmerle JF. Autocrine regulation of growth in cultured human intestinal muscle by growth factors. Gastroenterology 113: 817-824, 1997.
19. Kuemmerle JT. Endogenous IGF-I regulates IGF binding protein production in human intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 278: G710-G717, 2000.
20. Lee SK, Goyal M, de Miguel M, Thomas P, Wharram B, Dysko R, Phan S, Killen PD, and Wigging RC. Renal biopsy collagen I mRNA predicts scarring in rabbit anti-GBM disease: comparison with conventional measures. Kidney Int 52: 1000-1015, 1997.
21. Leventhal PS, Randolph AE, Vesbit TE, Schenone A, Windebank AJ, and Feldman EL. Insulin-like growth factor-II: a paracrine growth factor in human neuroblastoma cells. Exp Cell Res 221: 179-186, 1995.
22. Liu JP, Baker J, Perkins AS, Robertson EJ, and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I and type 1 IGF receptor. Cell 75: 59-72, 1993.
23. Lund PK and Zimmermann EM. Insulin-like growth factors and inflammatory bowel disease. Baillieres Clin Gastroenterol 10: 83-96, 1996.
24. Mangiacapra FJ, Roof SL, Ewton DZ, and Florini JR. Paradoxical decrease in myf-5 messenger RNA during induction of myogenic differentiation by insulin-like growth factors. Mol Endocrinol 6: 2038-2044, 1992.
25. Nam TJ, Busby WH Jr, and Clemmons DR. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. Endocrinology 137: 5530-5536, 1996.
26. Phan SH. Role of the myofibroblast in pulmonary fibrosis. Kidney Int 49: S46-S48, 1996.
27. Rechler M. Insulin-like growth factor binding proteins. Vitam Horm 47: 1-114, 1993.
28. Stallmach A, Schuppan D, Riese HH, Matthes H, and Riechen EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 102: 1920-1929, 1990.
29. Song H, Beattie J, Campbell IW, and Allan GJ. Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5. J Mol Endocrinol 24: 43-51, 2000.
30. Zadeh SM and Binoux M. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic actions of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138: 3069-3072, 1997.
31. Zeeh JM, Hoffman P, Sottili M, Ennes H, Eysselein VE, and McRoberts JA. Up-regulation of insulin-like growth factor-I binding proteins in experimental colitis in rats. Gastroenterology 108: 644-652, 1995.
32. Zeeh JM, Mohapatra N, Lund PK, Eysselein VE, and McRoberts JA. Differential expression and localization of IGF-I and IGF binding proteins in inflamed rat colon. J Recept Signal Transduct Res 18: 265-280, 1998.
33. Zeeh JM, Procaccino F, Hoffmann P, Zittel TT, Eysselein VE, and McRoberts JA. Colonic smooth muscle of rats is a major target of insulin-like growth factor-I in vivo and in vitro (Abstract). Gastroenterology 108: A1019, 1995.
34. Zheng B, Duan C, and Clemmons DR. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I. J Biol Chem 273: 8994-9000, 1998.
35. Zheng B, Clarke JB, Busby WH, Duan C, and Clemmons DR. Insulin-like growth factor binding protein-5 is cleaved by physiological concentrations of thrombin. Endocrinology 139: 1708-1714, 1998.
36. Zimmermann EM, Li L, Hou YT, Cannon M, Christman GM, and Bitar KN. IGF-1 induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 273: G875-G882, 1997.
37. Zimmermann EM, Sartor RD, McCall RD, Pardo M, Bender D, and Lund PK. Insulin-like growth factor I and interleukin 1β messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 105: 399-409, 1993.